RE:RE:What bashers don't want you to know...for any honest ppl on this or holders of SZLS i dont think anyone would disagree with the market for cancer diagnotics is huge and will only get bigger with an aging poopulation. what i dont see or have yet to see is how SZLS can create a market for themselves. we have yet to see any results from aristotle release and even this article , mentions grail?
at first i thought JHT is just bad a managing/ marketing this thing but my bigger fear is aristole is not as revolutionary as i originally thought and competitors have ate up any pontential market.
i hope im wrong but i havent seen anything to support SZLS being a viable investment opertunity let alone a thriving business.